NY-WEA
11.1.2022 13:09:07 CET | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA), today announced the global launch of its online entrepreneurship curriculum designed to inspire, educate, and empower women entrepreneurs around the world. The Online Entrepreneurship Certificate Programme was first announced during the United Nations General Assembly (UNGA 76) on the second anniversary of WEA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005443/en/
WEA is a multi-stakeholder strategic partnership convening six United Nations agencies: International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), United Nations Development Programme (UNDP), United Nations Global Compact (UNGC), UN Women, and Mary Kay. ITC is leading the capacity-building component of the multi-partnership.
Developed by ITC SheTrades and powered by Mary Kay in support of WEA, the guided Entrepreneurship Certificate Programme includes 27 interactive modules enriched with over 200 videos. The aim is to teach women entrepreneurs—aspiring or veteran—the skills to design and set up businesses that have potential to be economically viable. Participants will learn how to adopt an entrepreneurship culture, develop ideas through design thinking and lean start-up methodologies, prepare a business model canvas, design a pitch, identify sources of funding, find the right partners, arrange for mentorship, build a team, and set up their businesses.
The Certificate Programme covers the seven key stages of business development :
- Certificate 1: Deciding to Become an Entrepreneur (6 modules),
- Certificate 2: Developing the Idea – Business Ideation (3 modules),
- Certificate 3: Business Modelling (4 modules),
- Certificate 4: Pitching the Business (4 modules),
- Certificate 5: Funding the Venture (3 modules),
- Certificate 6: Building up the Team (4 modules),
- Certificate 7: Setting up the Business (3 modules).
The WEA Online Entrepreneurship Certificate Programme is now accessible at the fingertips of millions of women directly on the ITC SheTrades website (www.shetrades.com/en/learn/e-learning ) and on the WEA website. It is currently available in English, Spanish, and French, with Arabic, Russian and Mandarin coming in 2022. It is free for all users of shetrades.com with no barrier to entry. Participants will receive a certificate upon completion of each of the seven key stages of business development .
“The world needs more women entrepreneurs,” said Deborah Gibbins, Chief Operating Officer at Mary Kay Inc . “Almost half of all women entrepreneurs claim to be driven by the desire to contribute to the great societal good. Their impact can be immense. The WEA Online Entrepreneurship Certificate Programme is a game-changer for women and girls around the world. With the right tools and support, there’s no limit to what women can do.”
“We must increase women’s participation in international trade, helping them scale their businesses so that they become the catalysts for more inclusive and sustainable communities. Women are powerful agents of change – and empowering women benefits whole societies,” said Pamela Coke-Hamilton, Executive Director of the International Trade Centre .
An official launch event will be held on January 18, 2022, at 15:00 CET in collaboration with Mary Kay. It will convene women entrepreneurs and women-owned businesses from the ITC SheTrades network around the world. The event will be hosted virtually in English and will serve as a platform to present the Entrepreneurship Certificate Programme, and upcoming in-country trainings. The SheTrades team will present the entrepreneurship curriculum as well as other tools available on www.shetrades.com . Register here to the launch of WEA’s first free Entrepreneurship Certificate Programme.
The launch of the WEA Certificate Programme on the ITC SheTrades eLearning platform will also be supplemented at the national level with on-the-ground training for women from developing countries interested in entrepreneurship and/or planning to integrate into regional and global value chains. The in-country training sessions will provide practical insight and expertise to women entrepreneurs and MSMEs and will take place virtually in Colombia, Brazil, Mexico and India. The training sessions will be held in Spanish (Colombia, Mexico), Portuguese (Brasil) and English (India). Sessions will focus on two main topics: “Competitiveness and Export Readiness” (19-20 January) and “Digital Marketing and e-commerce workshops” (1-3 February).
The contribution falls under ITC's “Empowering Women to Trade Programme” which contributes directly to ITC’s focus area 5 “Promoting and Mainstreaming Inclusive and Green Trade” and United Nations Sustainable Development Goals (SDGs) 5, 8 and 17.
WEA has committed to empower 5 million women entrepreneurs by 2030.
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-partnership initiative on women’s entrepreneurship convening six United Nations agencies and Mary Kay. International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay have committed to empower 5 million women entrepreneurs by 2030. The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate.com
. Follow us: Twitter and Instagram (@we_accelerator), Facebook and LinkedIn (@womensentrepreneurshipaccelerator).
About ITC SheTrades
The International Trade Centre’s SheTrades initiative aims to connect three million women to market by 2021 and rallies stakeholders around the world to work together to address trade barriers and create greater opportunities for women entrepreneurs. It is supported by a web and mobile digital platform. For more information, please visit SheTrades.com: https://www.shetrades.com/en
.
About the International Trade Centre
The International Trade Centre is the joint agency of the World Trade Organization and the United Nations. ITC assists small and medium-sized enterprises in developing and transition economies to become more competitive in global markets, thereby contributing to sustainable economic development within the frameworks of the Aid-for-Trade agenda and the United Nations’ Sustainable Development Goals. For more information, visit www.intracen.org
. Follow ITC on Twitter
| Facebook
| LinkedIn
| Instagram
| Flickr
View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005443/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom